Search Results - "Wei, Juying"

Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre by Wang, Huafeng, Wang, Ming, Wei, Juying, Wang, Lei, Mao, Liping, Jin, Jie

“…Objective To retrospectively analyse outcomes in patients with primary central nervous system lymphoma (PCNSL), which is a malignant CNS non-Hodgkin’s lymphoma…”
Get full text

Inactivated vaccine dosage and serum IgG levels correlate with persistent COVID-19 infections in hematologic malignancy patients during the Omicron Surge in China by Ye, Li, Yang, Ye, Zhang, Xuewu, Wang, Lu, Zhu, Li, Li, Xia, Zhou, Yile, Zheng, Xiaolong, Zhou, Xinping, Ren, Yanling, Ma, Liya, Xu, Gaixiang, Yang, Chunmei, Wang, Huafeng, Zhou, De, Yang, Min, Ye, Xingnong, Wei, Juying, Yu, Wenjuan, Qian, Jiejing, Lou, Yinjun, Xie, Wanzhuo, Huang, Jian, Meng, Haitao, Jin, Jie, Tong, Hongyan

“…The essence of this scholarly work was to carefully outline the key factors intensifying the virulence and protracted contagion of COVID-19, particularly among…”
Get full text

A hybrid energy-based and AI-based screening approach for the discovery of novel inhibitors of JAK3 by Wei, Juying, Pan, Youlu, Shen, Zheyuan, Shen, Liteng, Xu, Lei, Yu, Wenjuan, Huang, Wenhai

“…The JAKs protein family is composed of four isoforms, and JAK3 has been regarded as a druggable target for the development of drugs to treat various diseases,…”
Get full text

Continuous therapy in HHV-8 negative Multicentric Castleman Disease and prolonged progression-free survival by Liu, Yi, Yin, Xuejiao, Ding, Shengnan, Ge, Jiaying, Ma, Liya, Yang, Min, Luo, Xuxia, Zhong, Chengli, Fang, Sishi, Yao, Qiumei, Zhu, Li, Yu, Wenjuan, Mao, Liping, Wei, Juying, Ye, Xingnong, Zhou, De, Tong, Hongyan, Meng, Haitao, Jin, Jie, You, Liangshun

“…The optimal treatment endpoints and duration of continuous therapy for multicentric Castleman disease (MCD) remain controversial. We retrospectively analyzed…”
Get full text

The crosstalk between autophagic and endo-/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses by You, Liangshun, Mao, Liping, Wei, Juying, Jin, Shenhe, Yang, Chunmei, Liu, Hui, Zhu, Li, Qian, Wenbin

“…T cells recognize antigen fragments from proteolytic products that are presented to them in the form of peptides on major histocompatibility complex (MHC)…”
Get full text

Effects of minor Ca addition on microstructure and mechanical properties of the Mg–4.5Zn–4.5Sn–2Al-based alloy system by Wei, Juying, Chen, Jihua, Yan, Hongge, Su, Bin, Pan, Xueqiang

“…► Effects of minor Ca on the Mg–Zn–Sn–Al alloy were firstly studied. ► The as-cast alloy with 0.2% Ca exhibits best mechanical properties. ► The as-rolled…”
Get full text

Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients by Xu, Yi, Shen, Huafei, Shi, Yuanfei, Zhao, Yanchun, Zhen, Xiaolong, Sun, Jianai, Li, Xueying, Zhou, De, Yang, Chunmei, Wang, Jinhan, Huang, Xianbo, Wei, Juying, Huang, Jian, Meng, Haitao, Yu, Wenjuan, Tong, Hongyan, Jin, Jie, Xie, Wanzhuo

“…Diffuse large B-cell lymphoma (DLBCL) is a kind of highly heterogeneous non-Hodgkin lymphoma, both in clinical and genetic terms. DLBCL is admittedly…”
Get full text

PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation by Hu, Chao, Yu, Mengxia, Ren, Yanling, Li, Kongfei, Maggio, Dominic M., Mei, Chen, Ye, Li, Wei, Juying, Jin, Jie, Zhuang, Zhengping, Tong, Hongyan

“…Patients with secondary acute myeloid leukemia (sAML) arising from myelodysplastic syndromes have a poor prognosis marked by an increased resistance to…”
Get full text

Fatal bronchial invasion of Scopulariopsis brevicaulis in an acute monocytic leukemia patient by Yang, Qing, Wei, Juying, Chen, Zhenjing

“…Abstract A case of fatal invasion of Scopulariopsis brevicaulis to the bronchus in an acute monocytic leukemia (M5 ) patient is described. This infection leads…”
Get full text

Repressing HIF-1α-induced HDAC9 contributes to the synergistic effect of venetoclax and MENIN inhibitor in KMT2Ar AML by Ling, Qing, Zhou, Yutong, Qian, Yu, Qian, Jiejing, Zhang, Yi, Wang, Jinghan, Zhu, Yanan, Zhou, Yile, Wei, Juying, Yang, Chunmei, Sun, Jie, Yu, Wenjuan, Jin, Jie, Zhang, Xiang

“…Abstract KMT2A -rearranged acute myeloid leukemia ( KMT2A r-AML) is an aggressive subtype of AML with poor response and prognosis. KMT2A r-AML has been…”
Get full text

Rituximab, lenalidomide and BTK inhibitor as frontline treatment for elderly or unfit patients with diffuse large B-cell lymphoma: a real-world analysis of single center by Zhu, Yanan, Zhang, Xiang, Wei, Juying, Yang, Chunmei, Tong, Hongyan, Mai, Wenyuan, Yang, Min, Qian, Jiejing, Mao, Liping, Meng, Haitao, Jin, Jie, Yu, Wenjuan

“…Abstract The combination of rituximab, lenalidomide, and Bruton’s tyrosine kinase inhibitor (BTKi) ibrutinib, followed by chemotherapy, has shown high efficacy…”
Get full text

The clinical impact of IKZF1 mutation in acute myeloid leukemia by Zhang, Xiang, Huang, Aijie, Liu, Lixia, Qin, Jiayue, Wang, Chengcheng, Yang, Min, Lou, Yinjun, Wang, Lei, Ni, Xiong, Hu, Xiaoxia, Tang, Gusheng, Zhang, Mengmeng, Cao, Shanbo, Mao, Liping, Qian, Jiejin, Xu, Weilai, Wei, Juying, Xu, Gaixiang, Meng, Haitao, Mai, Wenyuan, Yang, Chunmei, Zhu, Honghu, Tong, Hongyan, Yang, Jianmin, Yu, Wenjuan, Wang, Jianmin, Jin, Jie

“…Genetic heterogeneity poses a great challenge to the understanding and management of acute myeloid leukemia (AML). Knowledge of the IKZF1 mutation in AML…”
Get full text

Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease： a report of three cases by Zhou, Xinping, Wei, Juying, Lou, Yinjun, Xu, Gaixiang, Yang, Min, Liu, Hui, Mao, Liping, Tong, Hongyan, Jin, Jie

“…Castleman disease （CD） is an uncommon non-clonal lymphoproliferative disorder with unknown etiology. No standard therapy is recommended for relapsed/refractory…”
Get full text

Outcomes in refractory diffuse large B‐cell lymphoma: results from a multicenter real‐world study in China by Wang, Shuo, Wang, Li, Hu, Jianda, Qian, Wenbin, Zhang, Xi, Hu, Yu, Zhu, Qi, Chen, Bobin, Wu, Depei, Chang, Chung‐Chou H., Xu, Pengpeng, Zheng, Xiaoyun, Wei, Juying, Liu, Yao, Cui, Guohui, Tang, Yong, Ma, Yan, Huang, Haiwen, Yi, Hongmei, Zhao, Weili

“…Background Diffuse large B‐cell lymphoma (DLBCL) patients refractory to rituximab‐based immunochemotherapy have a dismal prognosis. However, the definition of…”
Get full text

Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma: A randomized phase III study by Zhong, Huijuan, Cheng, Shu, Zhang, Xi, Xu, Bing, Chen, Jiayi, Jiang, Xufeng, Xiong, Jie, Hu, Yu, Cui, Guohui, Wei, Juying, Qian, Wenbin, Huang, Xiaobing, Hou, Ming, Yan, Feng, Wang, Xin, Song, Yongping, Hu, Jianda, Liu, Yuanhua, Ma, Xuejun, Li, Fei, Wu, Chongyang, Chen, Junmin, Yu, Li, Bai, Ou, Xu, Jingyan, Zhu, Zunmin, Liu, Li, Zhou, Xin, Huang, Li, Tong, Yin, Niu, Ting, Wu, Depei, Zhang, Hao, Wang, Chaofu, Ouyang, Binshen, Yi, Hongmei, Song, Qi, Cai, Gang, Li, Biao, Liu, Jia, Li, Zhifeng, Xiao, Rong, Wang, Luqun, Jiang, Yujie, Liu, Yanyan, Zheng, Xiaoyun, Xu, Pengpeng, Huang, Hengye, Wang, Li, Chen, Saijuan, Zhao, Weili

“…Methotrexate, etoposide, dexamethasone, and pegaspargase (MESA) with sandwiched radiotherapy is known to be effective for early-stage extranodal natural…”
Get full text

Effects of cooling rate and pressure on microstructure and mechanical properties of sub-rapidly solidified Mg–Zn–Sn–Al–Ca alloy by Chen, Jihua, Wei, Juying, Yan, Hongge, Su, Bin, Pan, Xueqiang

“…► Effects of cooling rate and pressure on Mg alloy are firstly studied. ► Higher cooling rate promotes formation of grain boundary compound. ► Water-cooling…”
Get full text

CAG regimen for refractory or relapsed adult T‐cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study by Qian, Jie‐Jing, Hu, Xiaoxia, Wang, Ying, Zhang, Yi, Du, Juan, Yang, Min, Tong, Hongyan, Qian, Wen‐Bin, Wei, Juying, Yu, Wenjun, Lou, Yin‐Jun, Mao, Liping, Tao Meng, Hai, You, Liang‐Shun, Wang, Libing, Li, Xia, Huang, Xin, Cao, Li‐Hong, Zhao, Jian‐Zhi, Yan Yan, Xiao, Chen, Yu‐Bao, Chen, Yu, Zhang, Su‐Jiang, Jin, Jie, Hu, Jiong, Zhu, Hong‐Hu

“…Adult patients with relapsed or refractory T‐cell acute lymphoblastic leukemia (R/R‐T‐ALL) have extremely poor prognosis, representing an urgent unmet medical…”
Get full text

CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1-positive B-Cell Lymphoma by Liu, Hui, Lei, Wen, Zhang, Chaoting, Yang, Chunmei, Wei, Juying, Guo, Qunyi, Guo, Xiaojun, Chen, Zhilu, Lu, Ying, Young, Ken H, Lu, Zheming, Qian, Wenbin

“…CD19-specific chimeric antigen receptor (CAR) T-cell therapy is effective against refractory or relapsed (R/R) B-cell lymphoma, but the efficacy is hindered by…”
Get full text

Chidamide As Maintenance in Peripheral T-Cell Lymphoma for Patients in Response after Induction Therapy: A Single Center Retrospective Study by Zhu, Yanan, Wei, Juying, Yang, Chunmei, Xie, Wanzhuo, Tong, Yanhong, Yu, Wen-Juan, Jin, Jie

“…Background Peripheral T-cell lymphoma (PTCL) is a set of heterogeneous mature T- and natural killer cell neoplasms, most of which are associated with poor…”
Get full text

Tucidinostat Maintenance after Achieving Objective Response to First-Line Therapy in Peripheral T-Cell Lymphoma: A Single-Center Retrospective Case-Control Study by Zhu, Yanan, Yu, Wenjuan, Jin, Jie, Wei, Juying, Tong, Hongyan, Yang, Chunmei, Li, Xia, Xie, Wanzhuo

Get full text